David Lechner is currently the Area Vice President for VWR, part of Avantor. In his current role, he has commercial responsibility for all Pharmaceutical, Biotechnology and Industrial businesses within the Mid-Atlantic and Northeast Area. Mr. Lechner has over 25 years of experience in the pharmaceutical and biotechnology sector. Prior to assuming his current position, Mr. Lechner held the position of VWR’s Vice President, Strategic Partners, managing global customer relationships for VWR’s largest Pharmaceutical customers. In addition, Mr. Lechner has served as the President of the Hemophilia Association of New Jersey, July 2016 – June 2018, working with members of the Biopharma Industry to bring programs and assistance to members of the Hemophilia community. Mr. Lechner still currently serves on the Board of Director for the Hemophilia Association on New Jersey.